NIH's limited competition supports expansion and sustainability of biomedical research centers at eligible institutions in states with historically low NIH funding; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: January 25, 2027 (Applications) | May 25, 2027 (Applications) | September 25, 2027 (Applications) | January 25, 2028 (Applications) | May 25, 2028 (Applications) | September 25, 2028 (Applications) | January 25, 2029 (Applications) | May 25, 2029 (Final applications)
Funding Amounts: Up to $1.5 million in annual direct costs for up to five years, excluding consortium F&A costs
Summary: Supports expansion and sustainability of biomedical research centers, faculty, and research infrastructure at IDeA-eligible institutions.
Key Information: Limited competition requiring existing research capacity or qualifying COBRE support; clinical trials are not allowed.
The National Institute of General Medical Sciences (NIGMS), part of NIH, administers this P30 Center Core Grant opportunity under the Institutional Development Award (IDeA) program. It supports biomedical research capacity in jurisdictions that have historically received low levels of NIH funding. Centers must address broad, cohesive scientific areas of strategic importance to their institutions.
COBRE-E expands existing capacity by growing the faculty base and supporting research projects and core facilities. COBRE-S sustains that infrastructure through continued faculty development and consolidation of research cores. Both phases support mentoring and progress toward investigator independence, with plans to maintain research excellence beyond COBRE funding. The E-S track provides two five-year phases, with a maximum of 10 years of support.